Eli Lilly says its GLP-1 weight loss shot and pill now covered for millions of Americans

Eli Lilly announced that its GLP-1 based weight-loss injection and oral medication have been added to the formularies of the three largest pharmacy benefit managers. The company said this move makes the treatments available to millions of Americans through employer health plans.

The inclusion by the major PBMs is presented as a key step toward broader employer coverage of GLP-1 therapies, which have been in high demand for weight management.

Analysts note that while the coverage expansion is positive for patient access, further negotiations and cost considerations will influence how widely employers adopt these drugs.